| # | Side effect | Count |
|---|---|---|
| 0 | FATIGUE | 5334 |
| 1 | NAUSEA | 4565 |
| 2 | MALIGNANT NEOPLASM PROGRESSION | 4502 |
| 3 | DEATH | 3297 |
| 4 | DIARRHOEA | 3231 |
| 5 | NEUTROPENIA | 2553 |
| 6 | WHITE BLOOD CELL COUNT DECREASED | 2299 |
| 7 | VOMITING | 2288 |
| 8 | METASTASES TO BONE | 2233 |
| 9 | NEOPLASM PROGRESSION | 2208 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PIK3CA-ACTIVATED MUTATION | 167 | 0.5030 |
| 1 | CARBOHYDRATE ANTIGEN 15-3 INCREASED | 264 | 0.3469 |
| 2 | TUMOUR MARKER INCREASED | 900 | 0.1874 |
| 3 | METASTASES TO PLEURA | 173 | 0.1649 |
| 4 | BREAST CANCER METASTATIC | 1706 | 0.1587 |
| 5 | METASTASES TO SKIN | 163 | 0.1578 |
| 6 | METASTASES TO BONE | 2233 | 0.1359 |
| 7 | METASTASES TO LIVER | 1834 | 0.1042 |
| 8 | BREAST CANCER RECURRENT | 313 | 0.0990 |
| 9 | METASTASES TO SPINE | 330 | 0.0981 |